Abstract
Brachytherapy dose calculation algorithms that account for heterogeneous patient geometries have recently become commercially available. However, it is as yet unknown how the treatment plans produced by these new algorithms will compare to the current clinical standard, TG-43 algorithm when applied to patients. Ten clinical APBI brachytherapy treatment plans were randomly chosen from our clinical database. These plans were recomputed with the Oncentra® Advanced Collapsed Cone Engine (ACE) version 4.5 and Acuros™ BV version 13 and compared to the current standard TG-43-based algorithms treated at our institution with a Strut-Adjusted Volume Implant (SAVI).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
